,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['destiny-breast04', 'breast']
destiny-breast04 continues to be the most talked about session at #asco22 
Plan, consolidate data, and synthesize insights from life science conferences and social media with https://t.co/Fhm0QpaU5o, a product of @ZoomRx.